SERPINA4 and lung cancer: Kallistatin levels are significantly downregulated in the serum of lung-cancer patients, and both gene-delivery and recombinant-protein interventions of kallistatin establish its capacity to suppress angiogenesis, inflammation and tumor metastasis (107).